Key features and details | |
Cat. No. | MABL-3201 |
Name | Anti-VEGFR2 mAbs |
Clone No. | AFD- B1C4A7 |
From | Recombinant Antibody |
Isotype | Engineer antibody |
Application | Blocking, in vivo, SPR, ELISA |
Species Reactivity | Human |
Basic Information | |
Specificity | The antibody is specific for VEGFR2. |
Alternative Name | flk-1;FLK-1; KDR; Fetal liver kinase 1; Kinase insert domain receptor; Protein-tyrosine kinase receptor; EC:2.7.10.1; Vascular endothelial growth factor receptor 2; Vascular endothelial growth factor receptor |
UniProt | P35968 |
Immunogen | The original antibody was isolated by panning a phage display library against VEGFR2. |
Application Notes | The antibody, together with dsD7A8, was used for constructing the bispecific antibody (A7-A8)-LALA. The original and the bispecific antibody could strongly bind to the recombinant human VEGFR2 and mouse VEGFR2 (EC50 =0.107 nM and 0.466 nM for B1C4A7 and 0.128 nM and 0.598 nM for A7- A8 respectively). The bispecific antibody could strongly block ligand VEGF binding to its receptor VEGFR2 (IC50 for hVEGF-hVEGFR2 interaction was 1.29 nM for the bispecific antibody and 1.72 nM for B1C4A7 and IC50 for mVEGF-mVEGFR2 interaction was 0.801 nM for the bispecific antibody and 0.973 nM for B1C4A7). The original and bispecific antibodies could bind to KDR/PAE cell expressed human VEGFR2, mouse VEGFR2 (EC50 =0.522 nM and 0.533 nM, respectively). The bispecific antibody associated to VEGFR2 fast and dissociated slowly (KD = 47 pM for the bispecific and 752 pM for the original antibody). |
Antibody First Published | |
Note on publication | |
COA Information (For reference only, actual COA shall prevail) | |
Size | 100 μg Purified antibody. |
Concentration | 1 mg/ml. |
Purification | Protein A affinity purified |
Buffer | PBS with 0.02% Proclin 300. |
Concentration | 1 mg/ml. |
Storage Recommendation | Store at 4⁰C for up to 3 months. For longer storage, aliquot and store at - 20⁰C. |